+
Shelter Pharma Receives International Purchase Orders
ECONOMY & POLICY

Shelter Pharma Receives International Purchase Orders

Shelter Pharma Limited (Shelter Pharma) has informed the stock exchange that it received significant export purchase orders from Genet International. The intimation was filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements and was dated 27 July 2026. The orders were received in the normal course of business and will be executed as per mutually agreed timelines.

The purchase orders, valued in United States dollar (USD), cover supply of veterinary feed supplements including Feedmin Bolus (2000 boxes at USD2,700), RegulIn Bolus (2500 boxes at USD3,375), Lactocal Gel (1200 pieces at USD3,360) and Buta-B Bolus (1500 boxes at USD2,850). The company has appended detailed order specifications and product-wise quantities and values in the annexure to the filing. Execution will follow the purchase order schedule and applicable export compliance procedures.

The aggregate consideration for the orders is USD12,285. The buyer is an international entity and the company has described the transaction as a normal course commercial sale. The promoters and promoter group have no interest in the buyer and the transaction does not constitute a related party transaction. The filing also states that the transaction is not conducted at arm's length basis.

Shelter Pharma indicated that the execution of the export orders is expected to strengthen its global presence and support its export business and revenue growth. The company has requested that the exchange take the filing on record; the notice bears the signature of the managing director and is dated 27 July 2026 from Ahmedabad. The company noted that such orders are in line with its strategy to deepen international engagement and to diversify export markets, and it will monitor progress against the delivery schedule.

Shelter Pharma Limited (Shelter Pharma) has informed the stock exchange that it received significant export purchase orders from Genet International. The intimation was filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements and was dated 27 July 2026. The orders were received in the normal course of business and will be executed as per mutually agreed timelines. The purchase orders, valued in United States dollar (USD), cover supply of veterinary feed supplements including Feedmin Bolus (2000 boxes at USD2,700), RegulIn Bolus (2500 boxes at USD3,375), Lactocal Gel (1200 pieces at USD3,360) and Buta-B Bolus (1500 boxes at USD2,850). The company has appended detailed order specifications and product-wise quantities and values in the annexure to the filing. Execution will follow the purchase order schedule and applicable export compliance procedures. The aggregate consideration for the orders is USD12,285. The buyer is an international entity and the company has described the transaction as a normal course commercial sale. The promoters and promoter group have no interest in the buyer and the transaction does not constitute a related party transaction. The filing also states that the transaction is not conducted at arm's length basis. Shelter Pharma indicated that the execution of the export orders is expected to strengthen its global presence and support its export business and revenue growth. The company has requested that the exchange take the filing on record; the notice bears the signature of the managing director and is dated 27 July 2026 from Ahmedabad. The company noted that such orders are in line with its strategy to deepen international engagement and to diversify export markets, and it will monitor progress against the delivery schedule.

Related Stories

Gold Stories

Next Story
Infrastructure Transport

Mumbai-Ahmedabad Bullet Train’s Surat-Vapi Section Set for 2027

The first section of the Mumbai-Ahmedabad Bullet Train corridor, linking Surat and Vapi, is targeted to begin services in 2027. Construction is expected to be completed by December 2026, while Railway Minister Ashwini Vaishnaw has indicated that an inauguration could take place around the middle of 2027. The National High Speed Rail Corporation (NHSRCL) said the train being manufactured in India is expected to reach the tracks around April or May 2027. The train will undergo extensive testing before the section is opened for passenger services. The project began construction in 2021 and includ..

Next Story
Infrastructure Transport

Indian Railways Approves Four Projects Worth Rs. 7.36 bn Across Four States

Indian Railways has approved four projects with a combined value of Rs. 7.36 bn across Uttar Pradesh, Maharashtra, Andhra Pradesh and Gujarat. The programme covers train protection, signalling, electric traction supply and a road overbridge, with each project assigned to a different railway zone. In Uttar Pradesh, Rs. 2.52 bn has been approved to extend the Kavach 4.0 automatic train protection system across 607.7 km in the Lucknow Division of North Eastern Railway. The system monitors train movements and can apply the brakes if a driver fails to observe a signal or exceeds a safe speed. The w..

Next Story
Infrastructure Urban

Chandru Raheja Sells 1.49% Stake in Mindspace REIT for Rs. 5 bn

Billionaire Chandru Lachmandas Raheja has sold a 1.49 per cent holding in Mindspace Business Parks REIT for Rs. 5 bn through a bulk deal on the BSE. The transaction involved 9.9 mn units and was executed at an average price of Rs. 505 per unit, according to exchange data. Following the sale, units of Mindspace Business Parks REIT were trading 0.18 per cent lower at Rs. 504.05 on Tuesday. Exchange data did not identify the buyers involved in the transaction. Raheja is the chairman of real estate company K Raheja Corp. The sale involved 99,00,990 units, representing 1.49 per cent of the Mumbai-b..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code